Global Neuromodulation Devices Market Research Report 2021
Global Neuromodulation Devices Market Research Report 2021
Analysis of the Neuromodulation Devices Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Neuromodulation Devices Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Neuromodulation Devices Market Overview:
Global Neuromodulation Devices Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Neuromodulation Devices involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Neuromodulation Devices Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Neuromodulation Devices market in 2020.
Global Neuromodulation Devices Market Segmentation
By Type, Neuromodulation Devices market has been segmented into:
Deep Brain Stimulation (DBS) Systems
Spinal Cord Stimulator (SCS) Systems
Diaphragm Pacing System (DPS)
Respiratory Electrical Stimulation (RES)
Vagus Nerve Stimulation (VNS)
Gastric Electrical Stimulation (GES)
Transcranial Magnetic Stimulation (TMS)
Transcutaneous Electrical Nerve Stimulation (TENS)
By Application, Neuromodulation Devices market has been segmented into:
Chronic Pain
Parkinson's Disease
Urine Incontinence
Epilepsy
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Neuromodulation Devices market are:
Medtronic
Boston Scientific Corporation
St.Jude Medical
Synapse Biomedical
Nevro
Neurosigma
Neuropace
Neuronetics
Cyberonics
BioControl Medical
1. Market Overview of Neuromodulation Devices
1.1 Neuromodulation Devices Market Overview
1.1.1 Neuromodulation Devices Product Scope
1.1.2 Market Status and Outlook
1.2 Neuromodulation Devices Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Neuromodulation Devices Historic Market Size by Regions (2015-2020)
1.4 Neuromodulation Devices Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Neuromodulation Devices Sales Market by Type (2015-2026)
2.1 Global Neuromodulation Devices Historic Market Size by Type (2015-2020)
2.2 Global Neuromodulation Devices Forecasted Market Size by Type (2021-2026)
2.3 Deep Brain Stimulation (DBS) Systems
2.4 Spinal Cord Stimulator (SCS) Systems
2.5 Diaphragm Pacing System (DPS)
2.6 Respiratory Electrical Stimulation (RES)
2.7 Vagus Nerve Stimulation (VNS)
2.8 Gastric Electrical Stimulation (GES)
2.9 Transcranial Magnetic Stimulation (TMS)
2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
3. Covid-19 Impact Neuromodulation Devices Sales Market by Application (2015-2026)
3.1 Global Neuromodulation Devices Historic Market Size by Application (2015-2020)
3.2 Global Neuromodulation Devices Forecasted Market Size by Application (2021-2026)
3.3 Chronic Pain
3.4 Parkinson's Disease
3.5 Urine Incontinence
3.6 Epilepsy
3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Neuromodulation Devices Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Neuromodulation Devices Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Neuromodulation Devices Business
5.1 Medtronic
5.1.1 Medtronic Company Profile
5.1.2 Medtronic Neuromodulation Devices Product Specification
5.1.3 Medtronic Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Boston Scientific Corporation
5.2.1 Boston Scientific Corporation Company Profile
5.2.2 Boston Scientific Corporation Neuromodulation Devices Product Specification
5.2.3 Boston Scientific Corporation Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 St.Jude Medical
5.3.1 St.Jude Medical Company Profile
5.3.2 St.Jude Medical Neuromodulation Devices Product Specification
5.3.3 St.Jude Medical Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Synapse Biomedical
5.4.1 Synapse Biomedical Company Profile
5.4.2 Synapse Biomedical Neuromodulation Devices Product Specification
5.4.3 Synapse Biomedical Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Nevro
5.5.1 Nevro Company Profile
5.5.2 Nevro Neuromodulation Devices Product Specification
5.5.3 Nevro Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Neurosigma
5.6.1 Neurosigma Company Profile
5.6.2 Neurosigma Neuromodulation Devices Product Specification
5.6.3 Neurosigma Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Neuropace
5.7.1 Neuropace Company Profile
5.7.2 Neuropace Neuromodulation Devices Product Specification
5.7.3 Neuropace Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Neuronetics
5.8.1 Neuronetics Company Profile
5.8.2 Neuronetics Neuromodulation Devices Product Specification
5.8.3 Neuronetics Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Cyberonics
5.9.1 Cyberonics Company Profile
5.9.2 Cyberonics Neuromodulation Devices Product Specification
5.9.3 Cyberonics Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 BioControl Medical
5.10.1 BioControl Medical Company Profile
5.10.2 BioControl Medical Neuromodulation Devices Product Specification
5.10.3 BioControl Medical Neuromodulation Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Neuromodulation Devices Market Size (2015-2026)
6.2 North America Neuromodulation Devices Key Players in North America (2015-2020)
6.3 North America Neuromodulation Devices Market Size by Type (2015-2020)
6.4 North America Neuromodulation Devices Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Neuromodulation Devices Market Size (2015-2026)
7.2 East Asia Neuromodulation Devices Key Players in North America (2015-2020)
7.3 East Asia Neuromodulation Devices Market Size by Type (2015-2020)
7.4 East Asia Neuromodulation Devices Market Size by Application (2015-2020)
8. Europe
8.1 Europe Neuromodulation Devices Market Size (2015-2026)
8.2 Europe Neuromodulation Devices Key Players in North America (2015-2020)
8.3 Europe Neuromodulation Devices Market Size by Type (2015-2020)
8.4 Europe Neuromodulation Devices Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Neuromodulation Devices Market Size (2015-2026)
9.2 South Asia Neuromodulation Devices Key Players in North America (2015-2020)
9.3 South Asia Neuromodulation Devices Market Size by Type (2015-2020)
9.4 South Asia Neuromodulation Devices Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Neuromodulation Devices Market Size (2015-2026)
10.2 Southeast Asia Neuromodulation Devices Key Players in North America (2015-2020)
10.3 Southeast Asia Neuromodulation Devices Market Size by Type (2015-2020)
10.4 Southeast Asia Neuromodulation Devices Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Neuromodulation Devices Market Size (2015-2026)
11.2 Middle East Neuromodulation Devices Key Players in North America (2015-2020)
11.3 Middle East Neuromodulation Devices Market Size by Type (2015-2020)
11.4 Middle East Neuromodulation Devices Market Size by Application (2015-2020)
12. Africa
12.1 Africa Neuromodulation Devices Market Size (2015-2026)
12.2 Africa Neuromodulation Devices Key Players in North America (2015-2020)
12.3 Africa Neuromodulation Devices Market Size by Type (2015-2020)
12.4 Africa Neuromodulation Devices Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Neuromodulation Devices Market Size (2015-2026)
13.2 Oceania Neuromodulation Devices Key Players in North America (2015-2020)
13.3 Oceania Neuromodulation Devices Market Size by Type (2015-2020)
13.4 Oceania Neuromodulation Devices Market Size by Application (2015-2020)
14. South America
14.1 South America Neuromodulation Devices Market Size (2015-2026)
14.2 South America Neuromodulation Devices Key Players in North America (2015-2020)
14.3 South America Neuromodulation Devices Market Size by Type (2015-2020)
14.4 South America Neuromodulation Devices Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Neuromodulation Devices Market Size (2015-2026)
15.2 Rest of the World Neuromodulation Devices Key Players in North America (2015-2020)
15.3 Rest of the World Neuromodulation Devices Market Size by Type (2015-2020)
15.4 Rest of the World Neuromodulation Devices Market Size by Application (2015-2020)
16 Neuromodulation Devices Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Neuromodulation Devices Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|